

Science-led brands.
Built to #dontdecline.






Element Longevity is a next-generation biotics and nutrition company — building a portfolio of science-led D2C brands on a shared proprietary formulation foundation.
A Longevity Crisis Meets a Broken Market
The Burden
The Signal
The Gap
Why Existing Brands Fail
Transient Probiotics
Missing Keystones
Most probiotics are tourists, not residents. They fail to engraft or restore the 'Keystone Species' (like Bifido) essential for long-term gut resilience.
Human-native strains selected for permanent colonization — our core IP advantage.
Generic Formulas
The One-Size Flaw
Universal supplements ignore biological individuality. 95% of adults fail to get the specific medical-grade nutrition needed to fuel their unique microbiome.
Demand for precision medical nutrition targeting specific metabolic outcomes.
No Brand Moat
Commodity Trap
Supplement brands compete on price because the science is identical. Without a formulation moat, margin erodes under Amazon competition.
Science-led brands with proprietary strains command premium pricing and loyalty.
Zero Proof
No Feedback Loop
Customers have no way to know if a supplement is working. No feedback means churn is structural, not fixable by marketing spend.
Clinical outcomes data and real symptom relief create defensible retention.
Built on Bifidobacterium Science
The strains that disappear as we age — and that no mainstream brand has figured out how to restore.
Bifidobacterium adolescentis and Bifidobacterium longum are naturally abundant in healthy aging populations. They regulate carbohydrate metabolism, immune signaling, and gut barrier function. They decline with age, diet, and antibiotic use — and 99% of probiotic brands don't include them in any meaningful form.
Human-Native Strains
Selected using in vivo methods for persistence at significantly higher abundance than conventional probiotics. They colonize — not pass through.
Clinical Differentiator
Strains support gut barrier integrity and butyrate production — the mechanisms behind energy, immunity, and inflammation control. Measurable biology, not marketing.
Proprietary IP & Pipeline
Exclusive formulation relationships with leading biotech partners. R&D pipeline includes 4+ new Bifidobacterium strain SKUs across targeted health categories.
Element Longevity
Multi-strain synbiotic · High-efficacy restoration · Flagship
Holy Cow!
Targeted lactose relief · Bifido + precision prebiotic
Human Strain
Single-strain purity · B. adolescentis focus
R3VY
Metabolic performance · Gut-energy axis · Athletic
Signal to Solution
"I want to live longer..."
HIGH EFFICACY

"I think I have trouble digesting dairy..."
TARGETED RELIEF

"I researched this specific strain..."
SINGLE STRAIN

"I need gut support for my active lifestyle..."
METABOLIC PERFORMANCE

We decouple the Problem from the Brand to maximize conversion.
High-Signal Biological Use Cases
Signal identification
Monitor consumer search, social, and symptom data to identify unmet biological needs before they become crowded categories.
Formula assignment
Our proprietary Bifido stack maps directly to the identified signal. No R&D from scratch — we assign from a validated formulation library.
Brand creation
AI-assisted positioning, naming, creative, and packaging. A new brand from brief to launch-ready in weeks, not quarters.
Channel activation
Amazon, TikTok Shop, and DTC simultaneously. Paid, organic, and influencer playbooks pre-built for each consumer archetype.
Scale & compound
Real purchase and reorder data feeds the next brand. Each launch makes the engine smarter and cheaper to operate.
Pipeline: 3 new brands launch-ready · Athletic Performance Nutrition · Muscle Retention Formula · 4 more Bifido SKUs in development
The Science Works. The Numbers Prove It.



Four Brands. One Formulation Stack.

Element Longevity
The lead brand. Multi-strain synbiotic targeting longevity, gut restoration, and systemic inflammation. Clinically dosed, zero-bloat.

Holy Cow!
Once-daily lactose digestion support. Precision prebiotic + Bifido formula. Built for the 50M Americans with dairy sensitivity.

Human Strain
Single-strain purity for the science-informed buyer. B. adolescentis in research-grade concentration. No fillers, no blends.

R3VY
Gut-energy axis optimization for active adults. Bifido + targeted nutrition for metabolic performance and recovery.
Omnichannel from Day One
Amazon
PRIMARYSeller Central live. Products indexed and converting. Prime-eligible. Reviews building. The largest supplement discovery platform in North America.
Tik Tok Shop
GROWTHNative TikTok commerce. Short-form content drives discovery at sub-$15 CAC. Fastest growing supplement channel. Creator-led strategy active.
DTC Storefront
DIRECTShopify live. Full margin capture. Email and SMS retention sequences. Subscription protocols with 25% opt-in rate.
Retail Pilot
EXPANDINGRetail distribution pilot agreements in place. Multi-location rollout planned with brand selection per channel demographics.
Built to Scale. Partnerships Locked.
Co-Packing & Manufacturing
Top-tier co-packing partners secured with capacity to scale to 100k+ units/mo immediately. QA/QC protocols fully established.

Proprietary Science & R&D
Secured exclusive relationships for clinical-grade formulations and IP. R&D pipeline established with leading biotech partners.

Omnichannel Activation
DTC storefront, Amazon Seller Central, and TikTok Shop are live and transacting. Retail distribution pilot agreements in place.



Where Science-Led Brands Win
Our Advantage
- Human-native Bifidobacterium strains — not tourist probiotics
- Proprietary formulation IP — exclusive biotech R&D partnerships
- Clinical outcomes — 78% symptom reduction validated in under 90 days
- AI-assisted brand launch — faster and lower cost than any competitor
- Multi-brand architecture — one science stack, many consumer doors
- Zero-bloat precision prebiotic — a category-defining differentiator

Market Focus with Traction & Trajectory
TAM $10.8B | SAM $3.2B | SOM $160M
Lactose Intolerance / Probiotic Therapeutics
North American consumers; dietary supplements/probiotics segment. Growth: 7% CAGR.
TAM $101B | SAM $20B | SOM $1B
Precision Medicine / Digital Gut-Health Personalization
North America, digital health & microbiome personalization. Growth: 20% CAGR.
TAM $600B | SAM $120B | SOM $1.2B
Functional Foods & Beverages / Gut-Health and Longevity
North American probiotic/functional bevs, bars, powders. Growth: 10% CAGR.

Meet the Team

Haig Newton
CEO

Nick Perez
CMO

Darren Becket
CXO, Product & Education Lead

Dr. Challa
Investor & Advisor

Tim Lambrecht
Investor & Advisor

Dr. Cora
Compliance

Dr. Zorgani
Research

Wes
AMZ Marketing

Adam
Sales Los Angeles

Isher
Lead Engineer

Daniel
Lead Design

Kayla
Sales Denver
Financial Projections & Unit Economics
Unit
Economics
Use of Funds
1 Year Costs

Capital Pathways: Two Ways to Partner with Us
We have two distinct ways to get involved.
1. Equity Path (SAFE Note) OPEN
- $1M raise target
- $400k raised to date (equity)
- 20% discount on next round
- $5M valuation cap
- Supported by key advisors across biotech, wellness, and digital health
2. Strategic Path (Custom Product Partnerships)
- Joint venture or co-develop a custom product/plan within our ecosystem.
- Opportunity to sponsor or enable tailored wellness solutions in the app.
- Designed for multi-location retail, corporate wellness, or investors seeking scalable engagement.
- Strategic Lending Path (Current or Custom Product Partnerships)
Strategic partners may also provide capital in the form of convertible loans or growth financing, tied to product rollout, packaging, or audience expansion. This enables partners to directly accelerate growth while participating in future upside.


Join the Revolution
We are raising our Seed. Contact us for details.